Aptus Endosystems Completes $30 Million Series C Financing

Looks to Commercialization of Pioneering Endovascular Treatment
for Abdominal Aortic Aneurysms
Sunnyvale, CA — January 7, 2009 — Aptus Endosystems Inc., a medical device company developing advanced technology for the endovascular treatment of aortic aneurysms, today announced it has closed a $30 Million Series C financing.

"The Aortic Aneurysm Repair market is a significant opportunity with over $800M in worldwide sales in 2008, and growing. Aptus has successfully developed proprietary endograft and fixation technologies that more closely approximate how a surgeon performs open surgical repair of aortic aneurysms, the current gold standard for treatment. These technologies allow the physician to perform an endovascular repair that is more durable, more compliant and more applicable to a broader patient population. This positions Aptus for significant growth in the AAA market and our investors have recognized the value of what significant clinical outcomes and advanced technology development can produce." said Bob H. Katz, President & CEO, Aptus Endosystems Inc. "

Press Release >> http://www.aptusendosystems.com/News/Aptus%20Endosystems%20Funding%20Release%20-%20FINAL%201-7-09.pdf